BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10594540)

  • 1. Immunohistochemical investigation of the cellular infiltrates at the sites of allergoid-induced late-phase cutaneous reactions associated with pollen allergen-specific immunotherapy.
    Eberlein-König B; Jung C; Rakoski J; Ring J
    Clin Exp Allergy; 1999 Dec; 29(12):1641-7. PubMed ID: 10594540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophil activation and T lymphocyte infiltration in allergen-induced late phase skin reactions and classical delayed-type hypersensitivity.
    Gaga M; Frew AJ; Varney VA; Kay AB
    J Immunol; 1991 Aug; 147(3):816-22. PubMed ID: 1830598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of late local skin reactions during rush venom immunotherapy.
    Jung CM; Funk A; Rakoski J; Ring J
    Allergy; 1997 Jul; 52(7):717-26. PubMed ID: 9265986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between infiltrating CD4+ lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man.
    Frew AJ; Kay AB
    J Immunol; 1988 Dec; 141(12):4158-64. PubMed ID: 2974055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergoid-specific T-cell reaction as a measure of the immunological response to specific immunotherapy (SIT) with a Th1-adjuvanted allergy vaccine.
    von Baehr V; Hermes A; von Baehr R; Scherf HP; Volk HD; Fischer von Weikersthal-Drachenberg KJ; Woroniecki S
    J Investig Allergol Clin Immunol; 2005; 15(4):234-41. PubMed ID: 16433203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desensitization effect of preseasonal seven-injection allergoid immunotherapy with olive pollen on basophil activation: the efficacy of olive pollen-specific preseasonal allergoid immunotherapy on basophils.
    Gokmen NM; Ersoy R; Gulbahar O; Ardeniz O; Sin A; Unsel M; Kokuludag A
    Int Arch Allergy Immunol; 2012; 159(1):75-82. PubMed ID: 22572984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term preseasonal birch pollen allergoid immunotherapy influences symptoms, specific nasal provocation and cytokine levels in nasal secretions, but not peripheral T-cell responses, in patients with allergic rhinitis.
    Klimek L; Dormann D; Jarman ER; Cromwell O; Riechelmann H; Reske-Kunz AB
    Clin Exp Allergy; 1999 Oct; 29(10):1326-35. PubMed ID: 10520053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergen dose dependency of the early- and late-phase cutaneous response in the cynomolgus monkey.
    Tomkinson A; Morton M; Stevens L; Bowden A; Tepper J
    Clin Exp Allergy; 2009 Jul; 39(7):1080-7. PubMed ID: 19400909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact on Allergy-Related Cells of a Birch Pollen Allergoid, with and without Monophosphoryl Lipid A, in Comparison with the Native Equivalent.
    Worm M; Ernst D; Kraller M; Babina M
    Int Arch Allergy Immunol; 2017; 172(1):20-26. PubMed ID: 28219062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy with an alum-adsorbed Parietaria-pollen allergoid: a 2-year, double-blind, placebo-controlled study.
    Tari MG; Mancino M; Ghezzi E; Frank E; Cromwell O
    Allergy; 1997 Jan; 52(1):65-74. PubMed ID: 9062631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of T-cell receptor beta variable-gene usage in cutaneous late-phase reactions: implications for T-lymphocyte recruitment in cutaneous inflammation.
    Lessin SR; Benoit BM; Li G; Moskovitz A; Zweiman B
    Clin Diagn Lab Immunol; 1999 Jan; 6(1):85-8. PubMed ID: 9874669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivity of T cells with grass pollen allergen extract and allergoid.
    Kahler H; Stüwe H; Cromwell O; Fiebig H
    Int Arch Allergy Immunol; 1999 Oct; 120(2):146-57. PubMed ID: 10545769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti-IL-4: A randomized controlled trial.
    Chaker AM; Shamji MH; Dumitru FA; Calderon MA; Scadding GW; Makatsori M; Jones I; He QA; Subramanian KK; Arm JP; Durham SR; Schmidt-Weber CB
    J Allergy Clin Immunol; 2016 Feb; 137(2):452-461.e9. PubMed ID: 26531865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated up-dosing of subcutaneous immunotherapy with a registered allergoid grass pollen preparation.
    Pfaar O; van Twuijver E; Hecker H; Boot JD; van Ree R; Klimek L
    Int Arch Allergy Immunol; 2013; 160(4):420-4. PubMed ID: 23183541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction.
    Ying S; Kikuchi Y; Meng Q; Kay AB; Kaplan AP
    J Allergy Clin Immunol; 2002 Apr; 109(4):694-700. PubMed ID: 11941321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sublingual immunotherapy with grass monomeric allergoid on allergen-specific T-cell proliferation and interleukin 10 production.
    Burastero SE; Mistrello G; Falagiani P; Paolucci C; Breda D; Roncarolo D; Zanotta S; Monasterolo G; Rossi RE
    Ann Allergy Asthma Immunol; 2008 Apr; 100(4):343-50. PubMed ID: 18450120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophils, specific hyperreactivity and occurrence of late phase reaction in allergic rhinitis.
    Milanese M; Ricca V; Canonica GW; Ciprandi G
    Eur Ann Allergy Clin Immunol; 2005 Jan; 37(1):7-10. PubMed ID: 15745370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled evaluation of allergoid in the immunotherapy of ragweed hay fever.
    Norman PS; Lichtenstein LM; Kagey-Sobotka A; Marsh DG
    J Allergy Clin Immunol; 1982 Oct; 70(4):248-60. PubMed ID: 6181113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fel d 1-derived T cell peptide therapy induces recruitment of CD4+ CD25+; CD4+ interferon-gamma+ T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects.
    Alexander C; Ying S; B Kay A; Larché M
    Clin Exp Allergy; 2005 Jan; 35(1):52-8. PubMed ID: 15649266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.